Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 17/20 | 0.49 |
| ▸ | CA1 | P00915 | 16/20 | 0.49 |
| ▸ | CA2 | P00918 | 16/20 | 0.49 |
| ▸ | CA12 | O43570 | 8/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1688096 | 0.95 | CA9 (0.52) | CA9CA1CA2CA12CA14 | |
| SCHEMBL29837449 | 0.95 | CA9 (0.52) | CA9CA1CA2CA12CA14 | |
| SCHEMBL14426887 | 0.91 | CA9 (0.39) | CA9CA1CA2CA12CA14 | |
| SCHEMBL9906260 | 0.90 | DNASE1L3 (0.51) | CA9CA1CA2CA12CA14 | |
| SCHEMBL13678642 | 0.90 | CA9 (0.49) | CA9CA1CA2CA12CA14 | |
| SCHEMBL14426896 | 0.88 | CA9 (0.56) | CA9CA1CA2CA12CA14 | |
| SCHEMBL1688099 | 0.87 | FOLH1 (0.51) | CA9CA1CA2CA12USP2 | |
| SCHEMBL9906325 | 0.85 | FOLH1 (0.54) | CA9CA1CA2CA12USP2 | |
| SCHEMBL13678665 | 0.85 | ESR1 (0.52) | CA9CA1CA2CA12CA14 | |
| SCHEMBL9906321 | 0.85 | FOLH1 (0.55) | CA9CA1CA2CA12USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673399-B1 | DETECTING AND PROFILING MOLECULAR COMPLEXES | MONOGRAM BIOSCIENCES INC (US) | 2017-04-05 | — | — | EP | disclosed |
| US-8198031-B2 | Using epidermal growth factor receptor complexes to diagnose and prognose health in cancer patients; drug screening | MONOGRAM BIOSCIENCES, INC. (US) | 2012-06-12 | — | — | US | disclosed |
| EP-1540347-B1 | DETECTING RECEPTOR OLIGOMERIZATION | ACLARA BIOSCIENCES INC (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20090173631-A1 | Single Cell Analysis of Membrane Molecules | ACLARA BIOSCIENCES, INC. | 2009-07-09 | — | — | US | disclosed |
| US-20090011432-A1 | Detecting and Profiling Molecular Complexes | MONOGRAM BIOSCIENCES, INC. (US) | 2009-01-08 | — | — | US | disclosed |
| US-20080233602-A1 | Detecting and profiling molecular complexes | MONOGRAM BIOSCIENCES, INC. | 2008-09-25 | — | — | US | disclosed |
| US-7255999-B2 | Detection of preferential polypetide in sample; otain sample containing preferential polyeptide, electrophorese, incubate with probe, detect signal from probe and recover polypeptide | MONOGRAM BIOSCIENCES, INC. (US) | 2007-08-14 | — | — | US | disclosed |
| US-7160735-B2 | Tagged microparticle compositions and methods | MONOGRAM BIOSCIENCES, INC. (US) | 2007-01-09 | — | — | US | disclosed |